NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Natco Pharma's board has authorized a major fund-raising exercise via a rights issue of equity shares worth up to ₹1,300 crore. This capital infusion is intended to strengthen the balance sheet and will lead to a revised demerger scheme for its crop health division to maintain existing swap ratios.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
